Sonoma Pharmaceuticals (SNOA) Earnings Analysis
Sonoma Pharmaceuticals (SNOA) next reports earnings on 2026-08-06, consensus EPS -0.3 USD. Last quarter (2026-06-16) it missed with EPS -0.33 USD vs -0.24 USD est (-37.5%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SNOA next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.3 USD |
| Revenue estimate | 0.00B |
SNOA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-16 | -0.33 USD | -0.24 USD | -37.5% | Miss |
| 2025-08-07 | -0.37 USD | -0.51 USD | +27.5% | Beat |
| 2025-06-17 | -0.15 USD | -0.73 USD | +79.5% | Beat |
| 2025-02-05 | -0.59 USD | -0.8 USD | +26.3% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
SNOA valuation and analyst view
| Trailing P/E | -0.61 |
|---|---|
| Trailing EPS | -1.79955 USD |
| Price / book | 0.66 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (1 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Sonoma Pharmaceuticals (SNOA)'s next earnings date?
Sonoma Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.3 USD and revenue estimate of 0.00B.
Did SNOA beat earnings last quarter?
In its 2026-06-16 report, SNOA posted EPS of -0.33 USD versus a -0.24 USD estimate — a miss of 37.5%.
What is SNOA's earnings track record?
Over the last 4 reported quarters with consensus data, SNOA beat estimates 3 times (75%).
What is SNOA's current P/E ratio and EPS?
SNOA trades at a trailing P/E of -0.61 on trailing EPS of -1.799548950848792 USD.
What do analysts rate SNOA?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell).